Novacyt S.A. reiterates revenue guidance of £100 million for the full year 2021, excluding DHSC revenues, as announced on 22 June 2021.
Market Closed -
Other stock markets
|
After market 03:25:09 pm | |||
0.577 EUR | -3.83% | 0.578 | +0.17% |
Jun. 11 | Novacyt, UK Department of Health and Social Care Settle Dispute | MT |
Jun. 11 | Novacyt settles with UK government over Covid-19 test kit claims | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.07% | 45.77M | |
-11.22% | 142M | |
-19.17% | 61.17M | |
+0.54% | 56.86M |
- Stock Market
- Equities
- ALNOV Stock
- News Novacyt
- Novacyt S.A. Reiterate Revenue Guidance for the Full Year 2021